Initial Evaluation of the Novel Dopamine Transporter Radioligand [18F]FE-PE2I in Healthy Controls and Parkinson's Disease Patients

被引：0
|
作者：
Varrone, A. [1 ]
Forsberg, A. [1 ]
Nakao, R. [1 ]
Amini, N. [1 ]
Nag, S. [1 ]
Svenningsson, P. [1 ]
Halldin, C. [1 ]
Farde, L. [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP154
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] [18F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
    Kerstens, Vera S.
    Fazio, Patrik
    Sundgren, Mathias
    Halldin, Christer
    Svenningsson, Per
    Varrone, Andrea
    EJNMMI RESEARCH, 2023, 13 (01)
  • [22] [18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
    Vera S. Kerstens
    Patrik Fazio
    Mathias Sundgren
    Christer Halldin
    Per Svenningsson
    Andrea Varrone
    EJNMMI Research, 13
  • [23] High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter
    Moein, Mohammad Mahdi
    Dahl, Kenneth
    Meijer, Ellen
    Ferrat, Melodie
    Tegnebratt, Tetyana
    Saliba, Paul
    Norman, Fredrik
    Samen, Erik
    Steiger, Carsten
    Savitcheva, Irina
    Tran, Thuy
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S132 - S133
  • [24] Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [18F]FE-PE2I
    Nogami, Tsuyoshi
    Arakawa, Ryosuke
    Sakayori, Takeshi
    Ikeda, Yumiko
    Okubo, Yoshiro
    Tateno, Amane
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [25] In Vitro Ligand Binding Kinetics Explains the Pharmacokinetics of [18F]FE-PE2I in Dopamine Transporter PET Imaging
    Kukk, Siim
    Loog, Olavi
    Hiltunen, Jukka-Veli
    Jarv, Jaak
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (12): : 1292 - 1296
  • [26] Imaging With [18F]FE-PE2I Suggests a Non-Linear Relationship Between Dopamine Transporter Availability and Motor Symptom Severity in Patients With Non-Advanced Parkinson′s Disease
    Kerstens, V.
    Fazio, P.
    Sundgren, M.
    Halldin, C.
    Svenningsson, P.
    Varrone, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S208 - S209
  • [27] Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
    Sonni, Ida
    Fazio, Patrik
    Sehain, Martin
    Halldin, Christer
    Svenningsson, Per
    Farde, Lars
    Varrone, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (10) : 1529 - 1534
  • [28] Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
    Susanna Jakobson Mo
    Jan Axelsson
    Lars Jonasson
    Anne Larsson
    Mattias J. Ögren
    Margareta Ögren
    Andrea Varrone
    Linda Eriksson
    David Bäckström
    Sara af Bjerkén
    Jan Linder
    Katrine Riklund
    EJNMMI Research, 8
  • [29] Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECTa clinical comparison
    Mo, Susanna Jakobson
    Axelsson, Jan
    Jonasson, Lars
    Larsson, Anne
    Ogren, Mattias J.
    Ogren, Margareta
    Varrone, Andrea
    Eriksson, Linda
    Backstrom, David
    af Bjerken, Sara
    Linder, Jan
    Riklund, Katrine
    EJNMMI RESEARCH, 2018, 8
  • [30] Kinetic Analysis and Quantification of the Dopamine Transporter in the Non-Human Primate Brain with [11C]PE2I and [18F]FE-PE2I
    Varrone, A.
    Steiger, C.
    Toth, M.
    Takano, A.
    Guilloteau, D.
    Gulyas, B.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S223 - S223
12345